 | Up a level |
Everts-Graber, Judith; Wenger, Mathias; Oser, Sven; Studer, Ueli; Steiner, Christian; Ziswiler, Hans-Rudolf; Sromek, Karoline; Schmid, Gernot; Gahl, Brigitta; Häuselmann, HansJörg; Reichenbach, Stephan; Lehmann, Thomas (2024). The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland. Osteoporosis international, 35(9), pp. 1605-1613. Springer-Verlag 10.1007/s00198-024-07155-9
Lehmann, Oliver; Mineeva, Olga; Dinara, Veshchezerova; Häuselmann, Hansjörg; Guyer, Laura; Reichenbach, Stephan; Lehmann, Thomas; Demler, Olga; Everts-Graber, Judith (2024). Fracture prediction in a Swiss cohort. Journal of bone and mineral research, 39(8), pp. 1103-1112. Oxford University Press 10.1093/jbmr/zjae089
Everts-Graber, Judith; Bonel, Harald; Lehmann, Daniel; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2023). Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporosis international, 34(11), pp. 1961-1973. Springer-Verlag 10.1007/s00198-023-06863-y
Everts-Graber, Judith; Bonel, Harald; Lehmann, Daniel; Gahl, Brigitta; Häuselmann, HansJörg; Studer, Ueli; Ziswiler, Hans-Rudolf; Reichenbach, Stephan; Lehmann, Thomas (2023). Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study. Osteoporosis international, 34(11), p. 1975. Springer-Verlag 10.1007/s00198-023-06887-4
